Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1581-1590 of 2873 for cancer

Edit search filters
  1. Gene Therapy For HER-Positive Cancer (SENTRY-HER2)

    Jacksonville, FL, Rochester, MN

  2. A First In Man Trial For Patients With Cancer

    Rochester, MN

  3. Intervention For Children Undergoing Proton Radiation For Brain Cancer

    Rochester, MN

  4. BBO-11818 In Adult Subjects With KRAS Mutant Cancer

    Scottsdale/Phoenix, AZ

  5. A Safety Study Of SGN-LIV1A In Breast Cancer Patients

    Rochester, MN

  6. Veliparib And Topotecan Hydrochloride In Treating Patients With Solid Tumors, Relapsed Or Refractory Ovarian Cancer, Or Primary Peritoneal Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Study To Evaluate Whether Probiotics For Gut Microbiome Will Target Cancer Immune Microenvironment In Breast And Lung Cancer

    Jacksonville, FL

  8. A Study To Evaluate VSV-hIFNbeta-NIS To Treat Patients With Relapsed/Refractory Multiple Myleoma, Acute Myeloid Leukemia, Or T-cell Lymphoma

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. A Study Of Investigational Immunotherapy To Determine The Safety And Effectiveness Of Nivolumab And Daratumumab, With Or Without Pomalidomide And Dexamethasone, In Patients With Relapsed/Refractory Hematologic Malignancies

    Rochester, MN

  10. The MOTS (Medication Overuse Treatment Strategy) Trial

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer